4//SEC Filing
Davies Angela M. 4
Accession 0001127602-10-016845
CIK 0000729922other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 5:28 PM ET
Size
5.1 KB
Accession
0001127602-10-016845
Insider Transaction Report
Form 4
Davies Angela M.
Sr. VP and CMO, Oncology
Transactions
- Disposition to Issuer
Common Stock
2010-06-07$57.50/sh−16$920→ 0 total
Footnotes (1)
- [F1]Represents the number of shares of common stock that were canceled in exchange for a cash payment of $57.50 per share following the merger of Ruby Acquisition, Inc. with and into OSI Pharmaceuticals, Inc.
Documents
Issuer
OSI PHARMACEUTICALS INC
CIK 0000729922
Entity typeother
Related Parties
1- filerCIK 0001488772
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 5:28 PM ET
- Size
- 5.1 KB